Date | Chamber | Action |
3/10/2023 | House | Rule 19(a) / Re-referred to Rules Committee |
215 ILCS 5/155.37 |
215 ILCS 5/513b1 |
215 ILCS 5/513b1.1 new |
215 ILCS 5/513b1.3 new |
215 ILCS 5/513b1.5 new |
215 ILCS 124/35 new |
Date | Chamber | Action | 2/17/2023 | House | Filed with the Clerk by Rep. Will Guzzardi | 2/17/2023 | House | First Reading | 2/17/2023 | House | Referred to Rules Committee | 2/28/2023 | House | Assigned to Prescription Drug Affordability & Accessibility Committee | 3/10/2023 | House | Rule 19(a) / Re-referred to Rules Committee | 3/10/2023 | House | Rule 19(a) / Re-referred to Rules Committee | 3/30/2023 | House | Added Co-Sponsor Rep. Christopher "C.D." Davidsmeyer |
Back To Top |